Thrombophilia

MONDO:0002305

A condition characterized by an abnormally high level of thrombi. Causes include thrombotic thrombocytopenic purpura, disseminated intravascular coagulation, bone marrow disorders, and antiphospholipid antibody syndrome.

Also known as: excessive blood clotting, hypercoagulability, hypercoagulability state, hypercoagulable

104 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Sub-types

Thrombophilia due to thrombin defect (15) Thrombotic thrombocytopenic purpura (15) Acquired thrombotic thrombocytopenic purpura (13) Disseminated intravascular coagulation (13) Congenital thrombotic thrombocytopenic purpura (5) Thrombophilia due to activated protein C resistance (5) Hereditary antithrombin deficiency (3) Protein S deficiency (3) Acquired purpura fulminans (0) Disseminated intravascular coagulation in newborn (0) Factor 5 excess with spontaneous thrombosis (0) Heparin cofactor 2 deficiency (0) Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency (0) Hereditary thrombophilia due to congenital protein C deficiency (0) Hereditary thrombophilia due to congenital protein S deficiency (0) Inherited thrombophilia (0) Purpura fulminans (0) Thrombomodulin-related bleeding disorder (0) Thrombophilia due to protein C deficiency, autosomal dominant (0) Thrombophilia due to protein C deficiency, autosomal recessive (0)

Broader categories

Disease (618) Hematologic disorder (160) Blood coagulation disease (51) Human disease (14) Disease by body system or component (0)

Trials to join now! 37 Not yet recruiting 13 Not yet finished but already full! 14 Completed 36 Terminated 4

Thrombophilia

Sub-types

Broader categories

Tailored drug regimen shows promise for rare blood disorder

Can extra care after transplant help older patients live better?

Cancer drug combo shows promise for Hard-to-Treat bowel cancer

Tiny study on clotting disorder and artery health ends early